Sign in Pull a receipt

ANVS

Annovis Bio, Inc.

Healthcare · Biotechnology

$274.11 sample

-2.66 (-0.96%) 1D

Market cap

$235.8B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-20

Alerts

8

Price$274.11 +14.61% 3M daily closessample

278.22238.34

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 20SECForm 144 filed
Oct 12SEC8-K filed: material event
Oct 05INSInsider sell: General Counsel
Sep 25INSInsider buy: EVP, Operations
Sep 18SECDEF 14A filed
Sep 11INSInsider sell: Chief Executive Officer
Sep 03SECDEF 14A filed
Aug 28INSInsider sell: Chief Financial Officer

Sign up to see the real ANVS record →

Company facts

SEC EDGAR registration

Name: Annovis Bio, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -19sample, -100 to +100
Reporting currency: USD

Who is positioning in ANVS

sample

Insiders: 24 insider transactions over 90 days, net selling, $582.3M
Congress: 1 members traded over 90 days
Institutions · 13F: 26 funds hold $5.1B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$8.0B +16.4% y/y

Q4 2024Q3 2026

Inventory$4.4B +2.6% y/y

Q4 2024Q3 2026

Accounts receivable$3.3B +11.7% y/y

Q4 2024Q3 2026

Total debt$9.1B +14.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $55.5B +4.1% 3M
Sample peer B: $27.8B -7.4% 3M
Sample peer C: $203.0B -0.1% 3M
Sample peer D: $220.3B -10.4% 3M
Sample peer E: $190.1B +4.0% 3M